Response to Editorial Comment to Impact of prior local therapy on overall survival in men with metastatic castration-resistant prostate cancer: Results from Shared Equal Access Regional Cancer Hospital

被引：0
|
作者：
Patel, Devin N. [1 ]
Chapin, Brian F. [2 ]
Freedland, Stephen J. [1 ,3 ]
机构：
[1] Cedars Sinai Med Ctr, Div Urol, Los Angeles, CA 90048 USA
[2] Univ Texas MD Anderson Canc Ctr, Dept Urol, Houston, TX 77030 USA
[3] Vet Affairs Med Ctr, Div Urol, Durham, NC 27705 USA
来源：
INTERNATIONAL JOURNAL OF UROLOGY | 2018年 / 25卷 / 12期
关键词：
D O I：
10.1111/iju.13861
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1005 / 1005
页数：1
相关论文
共 50 条
  • [31] External validation of a prognostic model for overall survival (OS) in men with metastatic castration-resistant prostate cancer (mCRPC).
    Halabi, Susan
    Dutta, Sandipan
    Araujo, John C.
    Logothetis, Christopher
    Sternberg, Cora N.
    Armstrong, Andrew J.
    Carducci, Michael Anthony
    Chi, Kim N.
    De Bono, Johann S.
    Petrylak, Daniel Peter
    Fizazi, Karim
    Higano, Celestia S.
    Small, Eric Jay
    Kelly, William Kevin
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [32] Androgens and Overall Survival in Patients With Metastatic Castration-resistant Prostate Cancer Treated With Docetaxel
    Ryan, Charles J.
    Dutta, Sandipan
    Kelly, William K.
    Middleberg, Rob
    Russell, Carly
    Morris, Michael J.
    Taplin, Mary-Ellen
    Halabi, Susan
    CLINICAL GENITOURINARY CANCER, 2020, 18 (03) : 222 - +
  • [33] Re: Apalutamide and Overall Survival in Non-metastatic Castration-resistant Prostate Cancer
    van der Poel, Henk G.
    EUROPEAN UROLOGY, 2020, 78 (01) : 116 - 117
  • [34] Systemic Therapy in Men with Metastatic Castration-resistant Prostate Cancer: A Systematic Review
    Loblaw, D. A.
    Walker-Dilks, C.
    Winquist, E.
    Hotte, S. J.
    CLINICAL ONCOLOGY, 2013, 25 (07) : 406 - 430
  • [35] IMPACT OF PRIOR LOCAL THERAPY ON SURVIVAL IN MEN RECEIVING CHEMOTHERAPY FOR METASTATIC PROSTATE CANCER
    Adejoro, Oluwakayode
    Elliott, Sean
    Konety, Badrinath
    JOURNAL OF UROLOGY, 2012, 187 (04): : E386 - E387
  • [36] Impact of DNA damage repair defects on response to radium-223 and overall survival in metastatic castration-resistant prostate cancer
    van der Doelen, Maarten J.
    Velho, Pedro Isaacsson
    Slootbeek, Peter H. J.
    Naga, Samhita Pamidimarri
    Bormann, Maren
    van Helvert, Sjoerd
    Kroeze, Leonie I.
    van Oort, Inge M.
    Gerritsen, Winald R.
    Antonarakis, Emmanuel S.
    Mehra, Niven
    EUROPEAN JOURNAL OF CANCER, 2020, 136 : 16 - 24
  • [37] Predicting Time From Metastasis to Overall Survival in Castration-Resistant Prostate Cancer: Results From SEARCH
    Moreira, Daniel M.
    Howard, Lauren E.
    Sourbeer, Katharine N.
    Amarasekara, Hiruni S.
    Chow, Lydia C.
    Cockrell, Dillon C.
    Pratson, Connor L.
    Hanyok, Brian T.
    Aronson, William J.
    Kane, Christopher J.
    Terris, Martha K.
    Amling, Christopher L.
    Cooperberg, Matthew R.
    Freedland, Stephen J.
    CLINICAL GENITOURINARY CANCER, 2017, 15 (01) : 60 - 66
  • [38] The Impact of Obesity on Overall and Cancer Specific Survival in Men With Prostate Cancer EDITORIAL COMMENT
    Inman, Brant A.
    JOURNAL OF UROLOGY, 2009, 182 (01): : 117 - 117
  • [39] PREDICTORS OF SKELETAL RELATED EVENTS AND OVERALL MORTALITY IN MEN WITH METASTATIC, CASTRATION-RESISTANT PROSTATE CANCER: RESULTS FROM THE SEARCH DATABASE
    Tablazon, Ingrid Lorese
    Howard, Lauren
    De Hoedt, Amanda
    Aronson, William
    Kane, Christopher
    Amling, Christopher
    Cooperberg, Matthew
    Terris, Martha
    Freedland, Stephen
    Williams, Stephen
    JOURNAL OF UROLOGY, 2019, 201 (04): : E499 - E499
  • [40] Interpreting the impact of apalutamide on overall survival among patients with non-metastatic castration-resistant prostate cancer
    McCaw, Z. R.
    Wei, L. -J.
    Ludmir, E. B.
    ANNALS OF ONCOLOGY, 2020, 31 (03) : 438 - 440
12345